Deal slippage diagnosis is the systematic analysis of why deals that should close this quarter keep pushing to next quarter—costing you 20-40% of your forecasted revenue. It’s the process of identifying the root causes behind deals that perpetually move from “closing this month” to “probably next month” in your pipeline. Picture this: It’s Friday afternoon.
Picture this: A founder at $800K ARR watches competitors land $2M enterprise deals with major health systems while they’re still pitching rule-based decision trees. Clinical decision support AI implementation is the strategic capability that separates B2B healthcare companies that scale from those that stall — it’s the difference between being a vendor and becoming critical
AI demand forecasting for 3PL providers is the difference between burning cash on excess warehouse space and turning away profitable clients because you can’t scale fast enough. It’s a system that uses machine learning to predict demand patterns across multiple clients, SKUs, and seasonal variations—transforming 3PLs from reactive space managers into proactive growth partners. Picture
Picture this: A European SaaS founder lands in San Francisco, armed with a pitch deck that crushed it in Berlin, London, and Amsterdam. Six months later, they’re heading home with burned runway and zero US customers. US GTM for international SaaS companies requires fundamentally different thinking than what works in European markets — it’s not
- 1
- 2